Additionally, breast cancer patients predisposed to somatic mutations like CHEK2, ATM, BARDI, PALB2, RAD51C, TP53, PTEN, MLH1 and MLH2 are also at higher risk of developing breast cancer [108]. Here, CHEK2 is linked to breast carcinoma.